retatrutide when available Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Trial of next-gen weight-loss drug

For researchers experiencing significant constipation or nausea on tirzepatide alone, adding levocarnitine may not be the best choice

Considering promising preclinical data (Table 1) and clinical pilot study results in the GLP-2 analog, teduglutide may have potential to become a new therapeutic option in IBD treatment, showing higher response and remission rates in comparison to placebo (Buchman et al

A trial on body fat mass does not transfer to colonic transit time, and a trial in functional constipation does not automatically transfer to GLP-1 users on dose escalation

In der Praxis ist diese Darreichungsform auf den Krankenhausbereich beschrnkt , insbesondere bei bestimmten medizinischen Indikationen im Zusammenhang mit Stoffwechselstrungen oder Carnitinmangel

Brand-name medications, such as those made by Eli Lilly and Novo Nordisk, including Zepbound, Foundayo and Wegovy, will now be available through the end of 2027